Pathology & Laboratory Medicine

You are here


Dr. Selina Chen-Kiang to be Honored by the Leukemia & Lymphoma Society

Selina Chen-Kiang, PhD
Professor of Pathology and Laboratory Medicine

We are delighted to announce that the New York City Chapter of The Leukemia & Lymphoma Society (LLS) will be honoring Dr. Selina Chen-Kiang at the 2nd Annual Crimson Ball on Wednesday, April 24, 2019 at The Mandarin Oriental in New York City. LLS and their mission to find better treatments and a cure for blood cancer is a cause that is highly important to Dr. Chen-Kiang. For over 20 years she has worked tirelessly with LLS and the NYC Chapter as a Board member, advocate and researcher.

A renowned professor of pathology and laboratory medicine, and immunology at Weill Cornell Medicine, Dr. Chen-Kiang has received multiple LLS grants over the past two decades, enabling her seminal work on a therapy that targets enzymes that play vital roles in cell division and are implicated in multiple cancers.

We ask that you join us as we pay tribute to Dr. Chen-Kiang at the Crimson Ball for her significant contributions to LLS and cancer research. Please visit to purchase a ticket. If you are unable to join us on April 24th, we hope you will consider purchasing a tribute journal ad or making a donation to Fund the Fight in Selina’s honor.

Dr. David P. Hajjar Appointed as Executive Vice Chair of Pathology and Laboratory Medicine

David P. Hajjar, Ph.D.
Executive Vice Chair of Pathology and Laboratory Medicine

It is with great pleasure that I announce the appointment of David P. Hajjar, Ph.D. as Executive Vice Chair of Pathology and Laboratory Medicine, effective immediately. In this capacity, David and I have agreed to work closely on developing strategic and programmatic departmental initiatives, including space development, faculty recruitment and retention, and education. Hence, Dr. Hajjar and I will be closely engaged in further developing a strategic plan for the future direction of the department. He and I have agreed that this will not be done in a vacuum, that we will all work toward this common goal.

David knows our department well. He joined Cornell University Medical College in the Department of Pathology in 1978 as a research fellow, was granted tenure in 1986, and promoted to professor in 1989, one of the youngest to receive tenure in the history of the Medical College. His research focused on the role of herpes virus infection in atherogenesis, and delineating the role of nitric oxide in inflammation and cholesterol trafficking. From 1978 to the present, he has garnered more than $70 million dollars in grant support from extramural sources.  In the 1990’s, David’s administrative acumen and leadership abilities as the founding Director of the Center of Vascular Biology were recognized by the medical center. He served with distinction as Dean of the Cornell University Graduate School of Medical Sciences from 1997 to 2013. From 2000 to 2007, he served as Research Dean and Vice Provost of the Faculty; and from 2003 to 2013, he served as Executive Vice Dean and Executive Vice Provost at the Medical College.  David is now Dean Emeritus and Professor of Biochemistry and Pathology and Senior Advisor to Dean/Provost Augustine Choi. In 2016, he was promoted to University Distinguished Professor by Cornell University.

Weill Cornell Medicine Awarded $9 Million Prestigious Grant for Mantle Cell Lymphoma Research

Selina Chen-Kiang

Selina Chen-Kiang, PhD
Professor of Pathology and Laboratory Medicine

Weill Cornell Medicine has been awarded a five-year, $9 million Program Project Grant (P01) from the National Cancer Institute (NCI) to better understand how and why patients with an aggressive and incurable form of lymphoma initially respond to treatment, only to relapse over time. The findings may enable investigators to develop superior therapies that are effective, well tolerated and tailored to individual patients with mantle cell lymphoma.

The NCI, part of the National Institutes of Health, offers Program Project Grants to support integrated, multi-project research involving a number of independent investigators who together can improve scientific understanding on a common theme or disease area. This is the first P01 that is solely focused on MCL, which will seek to capitalize on the institution’s strengths in basic and translational research for blood malignancies.

Weill Cornell Medicine Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464 Fax: (212) 746-8192